Brown-Nagin, T. (2013). Two Americas in Healthcare: Federalism and Wars over Poverty from the New Deal-Great Society to Obamacare. Drake L. Rev., 62, 981.
Maier, S. L., Mannes, S., & Koppenhofer, E. L. (2017). The Implications of Marijuana Decriminalization and Legalization on Crime in the United States. Contemporary Drug Problems, 0091450917708790.
Maust, D. T., Bonar, E. E., Ilgen, M. A., Blow, F. C., & Kales, H. C. (2016). Agitation in Alzheimer disease as a qualifying condition for medical marijuana in the United States. The American Journal of Geriatric Psychiatry, 24(11), 1000-1003.
Moncrieff, A. R. (2012). Cost-Benefit Federalism: Reconciling Collective Action Federalism and Libertarian Federalism in the Obamacare Litigation and Beyond. American journal of law & medicine, 38(2-3), 288-325.
Single, E. W. (1989). The impact of marijuana decriminalization: an update. Journal of public health policy, 456-466.
Thompson, F. J., & Gusmano, M. K. (2014). The administrative presidency and fractious federalism: The case of Obamacare. Publius: The Journal of Federalism, 44(3), 426-450.
Wang, G. S., Le Lait, M. C., Deakyne, S. J., Bronstein, A. C., Bajaj, L., & Roosevelt, G. (2016). Unintentional pediatric exposures to marijuana in Colorado, 2009-2015. JAMA pediatrics, 170(9), e160971-e160971.